Abstract Introduction Accurate measurement of myasthenia gravis (MG) severity is required for appropriate clinical monitoring of patients with MG and assessment of the benefit of new treatments in clinical trials.Our objective was to explore how MG severity can be measured and to determine how the newly developed MG Symptoms Patient-Reported Outcom